Header Logo

Connection

ELIZABETH SHPALL to Bone Marrow Transplantation

Back to Details
This is a "connection" page, showing publications ELIZABETH SHPALL has written about Bone Marrow Transplantation.
ELIZABETH SHPALL
Connection Strength
2.180
Bone Marrow Transplantation
  1. American Society for Blood and Marrow Transplantation guidelines for training. Biol Blood Marrow Transplant. 2001; 7(10):577.
    View in: PubMed
    Score: 0.122
  2. FAHCT accreditation: common deficiencies during on-site inspections. Cytotherapy. 2000; 2(3):213-20.
    View in: PubMed
    Score: 0.114
  3. A prospective randomized trial of buffy coat versus CD34-selected autologous bone marrow support in high-risk breast cancer patients receiving high-dose chemotherapy. Blood. 1997 Dec 01; 90(11):4313-20.
    View in: PubMed
    Score: 0.099
  4. Histologic Grade 1 Is Associated With Increased Nonrelapsed Mortality in Lower Gastrointestinal Graft Versus Host Disease. Am J Surg Pathol. 2017 Nov; 41(11):1483-1490.
    View in: PubMed
    Score: 0.098
  5. High-dose chemotherapy for the treatment of breast and ovarian cancer. Curr Opin Oncol. 1997 Mar; 9(2):122-5.
    View in: PubMed
    Score: 0.094
  6. Future strategies for the treatment of advanced epithelial ovarian cancer using high-dose chemotherapy and autologous bone marrow support. Gynecol Oncol. 1994 Sep; 54(3):357-61.
    View in: PubMed
    Score: 0.079
  7. Amifostine (WR-2721) shortens the engraftment period of 4-hydroperoxycyclophosphamide-purged bone marrow in breast cancer patients receiving high-dose chemotherapy with autologous bone marrow support. Blood. 1994 Jun 01; 83(11):3132-7.
    View in: PubMed
    Score: 0.077
  8. High-dose therapy with autologous bone marrow transplantation for the treatment of solid tumors. Curr Opin Oncol. 1994 Mar; 6(2):135-8.
    View in: PubMed
    Score: 0.076
  9. Transplantation of enriched CD34-positive autologous marrow into breast cancer patients following high-dose chemotherapy: influence of CD34-positive peripheral-blood progenitors and growth factors on engraftment. J Clin Oncol. 1994 Jan; 12(1):28-36.
    View in: PubMed
    Score: 0.075
  10. The role and methodology for purging tumor from autologous bone marrow and peripheral blood progenitor cells. Med Oncol. 1994; 11(2):47-51.
    View in: PubMed
    Score: 0.075
  11. Positive selection of CD34+ hematopoietic progenitor cells for transplantation. Stem Cells. 1993 Oct; 11 Suppl 3:48-9.
    View in: PubMed
    Score: 0.074
  12. Connective tissue growth factor regulates adipocyte differentiation of mesenchymal stromal cells and facilitates leukemia bone marrow engraftment. Blood. 2013 Jul 18; 122(3):357-66.
    View in: PubMed
    Score: 0.072
  13. Role of autotransplantation in treatment of other solid tumors. Hematol Oncol Clin North Am. 1993 Jun; 7(3):663-86.
    View in: PubMed
    Score: 0.072
  14. High-dose chemotherapy and autologous bone marrow support as consolidation after standard-dose adjuvant therapy for high-risk primary breast cancer. J Clin Oncol. 1993 Jun; 11(6):1132-43.
    View in: PubMed
    Score: 0.072
  15. New strategies in marrow purging for breast cancer patients receiving high-dose chemotherapy with autologous bone marrow transplantation. Breast Cancer Res Treat. 1993; 26 Suppl:S19-23.
    View in: PubMed
    Score: 0.070
  16. Purging of autologous bone marrow for transplantation: the protection and selection of the hematopoietic progenitor cell. J Hematother. 1992; 1(1):45-54.
    View in: PubMed
    Score: 0.065
  17. Immunomagnetic purging of breast cancer from bone marrow for autologous transplantation. Bone Marrow Transplant. 1991 Feb; 7(2):145-51.
    View in: PubMed
    Score: 0.061
  18. 4-Hydroperoxycyclophosphamide purging of breast cancer from the mononuclear cell fraction of bone marrow in patients receiving high-dose chemotherapy and autologous marrow support: a phase I trial. J Clin Oncol. 1991 Jan; 9(1):85-93.
    View in: PubMed
    Score: 0.061
  19. Unrelated donor transplantation for acute myelogenous leukemia in first remission. Biol Blood Marrow Transplant. 2011 Jul; 17(7):1067-71.
    View in: PubMed
    Score: 0.060
  20. High-dose alkylating agent chemotherapy with autologous bone marrow support in patients with stage III/IV epithelial ovarian cancer. Gynecol Oncol. 1990 Sep; 38(3):386-91.
    View in: PubMed
    Score: 0.060
  21. Immunopharmacologic purging of breast cancer from bone marrow for autologous bone marrow transplantation. Prog Clin Biol Res. 1990; 333:321-35; discussion 336.
    View in: PubMed
    Score: 0.057
  22. Strategies for widening the use of cord blood in hematopoietic stem cell transplantation. Haematologica. 2006 May; 91(5):584-7.
    View in: PubMed
    Score: 0.044
  23. Consolidation with high-dose combination alkylating agents with bone marrow transplantation significantly improves disease-free survival in hormone-insensitive metastatic breast cancer in complete remission compared with intensive standard-dose chemotherapy alone. Biol Blood Marrow Transplant. 2006 Feb; 12(2):195-203.
    View in: PubMed
    Score: 0.043
  24. Quality of life among patients with Stage II and III breast carcinoma randomized to receive high-dose chemotherapy with autologous bone marrow support or intermediate-dose chemotherapy: results from Cancer and Leukemia Group B 9066. Cancer. 2005 Oct 15; 104(8):1580-9.
    View in: PubMed
    Score: 0.043
  25. Eltrombopag improves platelet engraftment after haploidentical bone marrow transplantation: Results of a Phase II study. Am J Hematol. 2024 04; 99(4):562-569.
    View in: PubMed
    Score: 0.038
  26. Umbilical Cord Blood Transplantation: Connecting Its Origin to Its Future. Stem Cells Transl Med. 2023 03 03; 12(2):55-71.
    View in: PubMed
    Score: 0.035
  27. Autologous transplantation of ex vivo expanded bone marrow cells grown from small aliquots after high-dose chemotherapy for breast cancer. Blood. 2000 Mar 15; 95(6):2169-74.
    View in: PubMed
    Score: 0.029
  28. Philadelphia chromosome-negative engraftment after autologous transplantation with granulocyte-macrophage colony-stimulating factor for chronic myeloid leukemia. Biol Blood Marrow Transplant. 1999; 5(6):394-9.
    View in: PubMed
    Score: 0.027
  29. High-dose chemotherapy in gynecologic malignancies. Cancer Treat Res. 1998; 95:277-85.
    View in: PubMed
    Score: 0.025
  30. Safeguarding the administration of high-dose chemotherapy: a national practice survey by the American Society for Blood and Marrow Transplantation. Biol Blood Marrow Transplant. 1997 Dec; 3(6):331-40.
    View in: PubMed
    Score: 0.025
  31. Ex vivo expansion of megakaryocyte progenitors: effect of various growth factor combinations on CD34+ progenitor cells from bone marrow and G-CSF-mobilized peripheral blood. Exp Hematol. 1997 Oct; 25(11):1125-39.
    View in: PubMed
    Score: 0.024
  32. Peripheral blood stem cell harvesting and CD34-positive cell selection. Cancer Treat Res. 1997; 77:143-57.
    View in: PubMed
    Score: 0.023
  33. Renal function in high dose chemotherapy and autologous hematopoietic cell support treatment for breast cancer. Kidney Int. 1996 Sep; 50(3):1026-31.
    View in: PubMed
    Score: 0.023
  34. Use of amifostine in bone marrow purging. Semin Oncol. 1996 Aug; 23(4 Suppl 8):44-8.
    View in: PubMed
    Score: 0.022
  35. American Society for Blood and Marrow Transplantation guidelines for training. Biol Blood Marrow Transplant. 1995 Nov; 1(1):56.
    View in: PubMed
    Score: 0.021
  36. Comparative assays of megakaryocyte progenitors in CD34+ peripheral blood progenitor cell fractions. Prog Clin Biol Res. 1994; 389:415-20.
    View in: PubMed
    Score: 0.019
  37. Randomized trial of high-dose chemotherapy with autologous bone marrow support as adjuvant therapy for high-risk, multi-node-positive malignant melanoma. J Natl Cancer Inst. 1993 Jul 07; 85(13):1080-5.
    View in: PubMed
    Score: 0.018
  38. The use of recombinant human granulocyte-macrophage colony-stimulating factor in autologous bone marrow transplantation. Prog Clin Biol Res. 1990; 338:121-8.
    View in: PubMed
    Score: 0.014
  39. A phase III study of infliximab and corticosteroids for the initial treatment of acute graft-versus-host disease. Biol Blood Marrow Transplant. 2009 Dec; 15(12):1555-62.
    View in: PubMed
    Score: 0.014
  40. High-dose combination cyclophosphamide, cisplatin, and melphalan with autologous bone marrow support. A clinical and pharmacologic study. Cancer Chemother Pharmacol. 1989; 23(6):377-83.
    View in: PubMed
    Score: 0.013
  41. High-dose combination alkylating agents with bone marrow support as initial treatment for metastatic breast cancer. J Clin Oncol. 1988 Sep; 6(9):1368-76.
    View in: PubMed
    Score: 0.013
  42. Effect of recombinant human granulocyte-macrophage colony-stimulating factor on hematopoietic reconstitution after high-dose chemotherapy and autologous bone marrow transplantation. N Engl J Med. 1988 Apr 07; 318(14):869-76.
    View in: PubMed
    Score: 0.013
  43. A phase I/II study of high-dose cyclophosphamide, cisplatin, and thioTEPA followed by autologous bone marrow and granulocyte colony-stimulating factor-primed peripheral-blood progenitor cells in patients with advanced malignancies. Cancer Chemother Pharmacol. 1996; 37(6):561-8.
    View in: PubMed
    Score: 0.005
  44. Myocardial ischemia associated with high-dose carmustine infusion. Cancer. 1991 Nov 01; 68(9):1910-2.
    View in: PubMed
    Score: 0.004
  45. Elimination of clonogenic breast cancer cells from human bone marrow. A comparison of immunotoxin treatment with chemoimmunoseparation using 4-hydroperoxycyclophosphamide, monoclonal antibodies, and magnetic microspheres. Cancer. 1991 Sep 15; 68(6):1272-8.
    View in: PubMed
    Score: 0.004
  46. High-dose carboplatin, cyclophosphamide, and BCNU with autologous bone marrow support: excessive hepatic toxicity. Cancer Chemother Pharmacol. 1990; 26(2):155-6.
    View in: PubMed
    Score: 0.004
  47. Elimination of malignant clonogenic breast cancer cells from human bone marrow. Cancer Res. 1989 Aug 15; 49(16):4659-64.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.